Evidence map›Paper›PMID 41076462›Full record

ArticleSurgery today2026

Survival benefit with lobectomy vs. sublobar resection in octogenarians with clinical stage IA lung cancer.

Satoshi Shiono, Makoto Endo, Hikaru Watanabe, Satoshi Takamori, Jun Suzuki

Abstract read
PubMed Publisher
In one paragraph

Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Satoshi ShionoDepartment of Surgery II, Faculty of Medicine, Yamagata University, 2-2-2, Iida-Nishi, Yamagata, 990-8585, Japan. shionosatoshi@me.com.
Makoto EndoDepartment of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
Hikaru WatanabeDepartment of Surgery II, Faculty of Medicine, Yamagata University, 2-2-2, Iida-Nishi, Yamagata, 990-8585, Japan.
Satoshi TakamoriDepartment of Surgery II, Faculty of Medicine, Yamagata University, 2-2-2, Iida-Nishi, Yamagata, 990-8585, Japan.
Jun SuzukiDepartment of Surgery II, Faculty of Medicine, Yamagata University, 2-2-2, Iida-Nishi, Yamagata, 990-8585, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo preserve the lung function, sublobar resection is considered better than lobectomy in octogenarians with clinical stage IA (c-stage IA) lung cancer. We explored the survival benefits of lobectomy versus sublobar resection in octogenarians undergoing surgery for c-stage IA lung cancer.

methodsBetween April 2004 and December 2024, 289 of the 2,650 patients who underwent surgery for lung cancer were octogenarians with c-stage IA. We analyzed survival and prognostic factors using propensity score matching to compare lobectomy and sublobar resection.

resultsThe median patient age was 82 years (range, 80-91 years), and the 90-day mortality rate was 0.7%. Lobectomy, segmentectomy, and wedge resection were performed in 109 (37.7%), 86 (30.0%), and 94 (32.5%) patients, respectively. The 5-year OS rates for lobectomy, segmentectomy, and wedge resection were 61.7%, 74.0%, and 63.0%, respectively (p = 0.382). After propensity score matching, no significant differences in survival were observed between the lobectomy and sublobar resection groups (p = 0.382). There was no difference in the 5-year cumulative incidence of cancer-related deaths between lobectomy (10.5%) and sublobar resection (8.7%) (p = 0.822). A multivariate analysis confirmed that lower performance status was a significant prognostic factor (p < 0.001).

conclusionsThe surgical procedure type did not affect overall survival in octogenarians with c-stage IA lung cancer, and performance status was a key prognostic factor.

Indexed as

Lung cancerOctogenarianSublobar resectionThoracic surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.